FREQUENCY OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH HEPATITIS C VIRUS
Main Article Content
Abstract
Objective: To determine the frequency of Hepatocellular Carcinoma (HCC) in patients with hepatitis C virus at tertiary care hospital.
Place and Duration of the Study: The study was conducted at the Department of Medicine, Peoples University of Medical and Health Sciences for Women, Nawabshah, Pakistan from 15-June-2025 to 15-September-2025.
Methodology: A consecutive sample of 103 patients aged 18–70 years diagnosed with hepatitis C virus infection was recruited. Demographic and clinical details were recorded and alpha-fetoprotein, liver ultrasonography and biphasic computed tomography were performed to identify hepatocellular carcinoma. Data were processed using Statistical Package for the Social Sciences version 26. Stratification was carried out using Chi-square or Fisher exact test, whereas binary logistic regression was applied to determine potential predictors. A p-value <0.05 was taken as statistically significant.
Results: The mean age was 53.30 ± 8.66 years, mean body mass index was 25.52 ± 2.19 kg/m² and mean duration of hepatitis C virus was 116.42 ± 56.79 months. Males were 75 (72.8%) and rural residents were 69 (67.0%). Diabetes mellitus was present in 26 (25.2%), hypertension in 39 (37.9%) and obesity in 18 (17.5%). Hepatocellular carcinoma was found in 15 (14.6%) patients. Diabetes mellitus was the only significant regression predictor (odds ratio 7.060, 95% confidence interval 1.753–28.437, p=0.006). It was higher in diabetic patients, 10 (38.5%), than non-diabetic patients, 5 (6.5%) (p<0.001).
Conclusion: Hepatocellular carcinoma was found in a proportion of hepatitis C virus patients, with diabetes mellitus showing significant association.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.